LATEST ALERTS
Paraguay: Member of parliament Alejandro Aguilera, from the ruling party National Republican Association, has submitted a bill to the parliament seeking to further develop
Paraguay: A group of senators of the Guasú Front (Frente Guasú), part of the opposition coalition, presented a bill yesterday (17th November) to
Paraguay: Last week, the National Health Surveillance Directorate (Dinavisa) issued Resolution 309/2022, which substitutes Ministry of Health Resolution 433/2019 to update the conditions, requirements and procedure for obtaining a licence to
Paraguay: Members of the Senate Committee for the Prevention and Fight Against Drug Trafficking and Related Crimes held a meeting on 21st September with
Paraguay: Last week the Ministry of Health issued Decree 7761/2022, wherein the maximum number of companies allowed to be granted a licence to
Paraguay: A First International Conference on Industrial Cannabis was held yesterday in the Bicameral Chamber of the National Congress, bringing together experts and legislators
Paraguay: On 6th June, the Commission on Prevention, Fight against Drug Trafficking and Related Crimes of the Senate debated a bill proposed in June 2021 seeking to
Paraguay: The National Health Surveillance Directorate (DINAVISA) stated on 4th June that only patients suffering from refractory epilepsy or multiple sclerosis are eligible to be registered
Paraguay: The Interinstitutional Commission on Industrial Hemp (COINCA) told CBD-Intel that the licence to process the hemp plant in order to obtain non-psychoactive
Paraguay: The National Health Surveillance Authority (DINAVISA) confirmed today to CBD-Intel that hemp extracts cannot be used in cosmetics. Despite the fact that cannabis extracts
Paraguay: The National Health Surveillance Agency (DINAVISA) recently issued Resolution 50/2022 to open a new period to apply for licences to cultivate and process cannabis,
